Today we have special guest Dr. Valerie Vaughn to talk about her new paper in Open Forum Infectious Diseases about inappropriate treatment and testing for asymptomatic bacteriuria.  Then we talk about the new ACTT-2 trial results of baricitinib plus remdesivir for COVID-19.  We also review the BioNTech/Pfizer vaccine safety and efficacy results, a noninvasive respiratory protocol to reduce intubations in COVID-19, and iron deficiency in acute heart failure. Testing and Treating Asymptomatic Bacteriuria Initiated in the EDBaricitinib Plus Remdesivir for COVID-19 (ACTT-2 trial)Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNon-invasive respiratory protocol for COVID-19Ferric Carboxymaltose for Acute HFrEF and Iron DeficiencyMusic from https://filmmusic.io"Sneaky Snitch" by Kevin MacLeod (https://incompetech.com)License: CC BY (http://creativecommons.org/licenses/by/4.0/)